Telix Pharmaceuticals H1 2023 Results Presentation

Telix Pharmaceuticals' H1 2023 results presentation covering the company's investigational radiopharmaceutical products and pipeline, including Illuccix® (Ga-68 gozetotide injection). The presentation outlines Telix's activities, financial results, and development progress as of August 2023.